Skip to main content
. 2016 Feb 25;6(2):e009387. doi: 10.1136/bmjopen-2015-009387

Table 1.

Study criteria and levels16–22

Criteria Definition Selected levels (%)
Stroke Percentage of stroke event reduction, compared with placebo 5, 15, 25, 35
MI Percentage of MI event reduction, compared with placebo 10, 40, 70
Myalgia Percentage of myalgia event, compared with placebo 0, 15, 30
Hepatotoxicity Percentage of hepatotoxicity event, compared with placebo 0, 3, 6

MI, myocardial infarction.